{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:56:19Z","timestamp":1787957779240,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["96-03-30-31841"],"award-info":[{"award-number":["96-03-30-31841"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biopha.2022.114022","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T05:02:46Z","timestamp":1668834166000},"page":"114022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Evaluating the expression pattern of the opioid receptor in pituitary neuroendocrine tumors (PitNET) and the role of morphine and naloxone in the regulation of pituitary cell line growth and apoptosis"],"prefix":"10.1016","volume":"157","author":[{"given":"S. Fahimeh","family":"Taghavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahsavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Adjaminezhad-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Sara","family":"Ghorbanhosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Tavakoli-Yaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2022.114022_bib1","first-page":"808","article-title":"Morphine: double-faced roles in the regulation of tumor development","volume":"20","author":"Zhang","year":"2018","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.biopha.2022.114022_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fmicb.2016.00970","article-title":"Opioids and viral infections: a double-edged sword","volume":"7","author":"Tahamtan","year":"2016","journal-title":"Front. Microbiol."},{"issue":"13","key":"10.1016\/j.biopha.2022.114022_bib3","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2022.114022_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/17476348.2020.1787836","article-title":"Opioids\/cannabinoids as a potential therapeutic approach in COVID-19 patients","volume":"14","author":"Tahamtan","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.114022_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s11010-022-04377-5","article-title":"Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression","volume":"477","author":"Haque","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.114022_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12967-021-02784-8","article-title":"The role of opioids in cancer response to immunotherapy","volume":"19","author":"Botticelli","year":"2021","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.114022_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0b013e31824b9512","article-title":"The \u03bc-opioid receptor in cancer progression: is there a direct effect?","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"issue":"30","key":"10.1016\/j.biopha.2022.114022_bib8","doi-asserted-by":"crossref","first-page":"27662","DOI":"10.1074\/jbc.M502593200","article-title":"Mu and kappa opioid receptors activate ERK\/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes","volume":"280","author":"Belcheva","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.114022_bib9","first-page":"319","article-title":"Pituitary adenomas: an overview","volume":"88","author":"Lake","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"2","key":"10.1016\/j.biopha.2022.114022_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10014-018-0314-3","article-title":"The 2017 WHO classification of pituitary adenoma: overview and comments","volume":"35","author":"Inoshita","year":"2018","journal-title":"Brain Tumor Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2022.114022_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12944-019-1089-1","article-title":"Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas","volume":"18","author":"Barooni","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.biopha.2022.114022_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3565(24)36608-X","article-title":"Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration","volume":"281","author":"Taylor","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2022.114022_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2022.114022_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbi.2009.03.007","article-title":"Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception","volume":"23","author":"Matsunaga","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2022.114022_bib15","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, Jama 310(20) (2013) 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"10.1016\/j.biopha.2022.114022_bib16","first-page":"1","article-title":"Ki-67 labeling index and Knosp classification of pituitary adenomas","author":"Yuhan","year":"2021","journal-title":"Br. J. Neurosurg."},{"issue":"1","key":"10.1016\/j.biopha.2022.114022_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12902-020-0515-8","article-title":"Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas","volume":"20","author":"Akbari","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2022.114022_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0028-3908(03)00024-8","article-title":"Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase","volume":"44","author":"Iglesias","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2022.114022_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12935-016-0315-4","article-title":"Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa","volume":"16","author":"Murad","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.biopha.2022.114022_bib20","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10616-016-9972-3","article-title":"Involvement of 15-lipoxygenase-1 in the regulation of breast cancer cell death induced by sodium butyrate","volume":"68","author":"Salimi","year":"2016","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biopha.2022.114022_bib21","doi-asserted-by":"crossref","unstructured":"S. Petersenn, Medical Therapy of Aggressive Pituitary Tumors, Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 129(3) (2021) 186\u2013193.","DOI":"10.1055\/a-1331-6939"},{"key":"10.1016\/j.biopha.2022.114022_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.748997","article-title":"Prediction of the recurrence of non-functioning pituitary adenomas using preoperative supra-intra sellar volume and tumor-carotid distance","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2022.114022_bib23","doi-asserted-by":"crossref","first-page":"5300381","DOI":"10.1155\/2021\/5300381","article-title":"Immune checkpoints: therapeutic targets for pituitary tumors","volume":"2021","author":"Nie","year":"2021","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.biopha.2022.114022_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/AJP.0b013e3181850df6","article-title":"The impact of opioids on the endocrine system","volume":"25","author":"Katz","year":"2009","journal-title":"Clin. J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2022.114022_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clin. J. Pain."},{"issue":"8","key":"10.1016\/j.biopha.2022.114022_bib26","first-page":"2539","article-title":"The effects of opiate agonists on growth hormone and prolactin release in rats","volume":"39","author":"Shaar","year":"1980","journal-title":"Fed. Proc."},{"issue":"11","key":"10.1016\/j.biopha.2022.114022_bib27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1139\/y88-226","article-title":"Morphine can stimulate prolactin release independent of a dopaminergic mechanism","volume":"66","author":"Shin","year":"1988","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.114022_bib28","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.bja.2018.09.030","article-title":"The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target","volume":"122","author":"Chen","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2022.114022_bib29","doi-asserted-by":"crossref","first-page":"i103","DOI":"10.1093\/bja\/aeu165","article-title":"Increased \u03bc-opioid receptor expression in metastatic lung cancer","volume":"113","author":"Singleton","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.biopha.2022.114022_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","article-title":"Overexpression of the \u03bc-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.biopha.2022.114022_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091577","article-title":"The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer","volume":"9","author":"Lennon","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2022.114022_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119541","article-title":"Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma","volume":"278","author":"Gorur","year":"2021","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.biopha.2022.114022_bib33","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2022.114022_bib34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.peptides.2010.05.002","article-title":"A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro","volume":"31","author":"Lazarczyk","year":"2010","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.biopha.2022.114022_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00210-011-0672-4","article-title":"The role of morphine in regulation of cancer cell growth","volume":"384","author":"Gach","year":"2011","journal-title":"Naunyn Schmiede 'S. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2022.114022_bib36","article-title":"In vitro growth effects of morphine and naloxone on various head and neck squamous cell cancer cell lines","author":"Denton","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2022.114022_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3389\/fnins.2019.01122","article-title":"Morphine efficacy, tolerance, and hypersensitivity are altered after modulation of SUR1 subtype K(ATP) channel activity in mice","volume":"13","author":"Fisher","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.114022_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2010.10.010","article-title":"Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH\u2083 pituitary tumor cells","volume":"280","author":"Huang","year":"2011","journal-title":"Toxicology"},{"issue":"17","key":"10.1016\/j.biopha.2022.114022_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.91.17.8042","article-title":"Agonists and antagonists bind to different domains of the cloned kappa opioid receptor","volume":"91","author":"Kong","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2022.114022_bib40","first-page":"857","article-title":"Induction of apoptosis by morphine in human tumor cell lines in vitro","volume":"27","author":"Hatsukari","year":"2007","journal-title":"Anticancer Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.114022_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tox.2008.11.015","article-title":"Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways","volume":"256","author":"Hsiao","year":"2009","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.biopha.2022.114022_bib42","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.21037\/jgo-20-394","article-title":"Morphine promotes angiogenesis by activating PI3K\/Akt\/HIF-1\u03b1 pathway and upregulating VEGF in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2022.114022_bib43","first-page":"1846","article-title":"G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation","volume":"63","author":"Tegeder","year":"2003","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.biopha.2022.114022_bib44","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/0024-3205(89)90548-1","article-title":"Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells","volume":"45","author":"Puttfarcken","year":"1989","journal-title":"Life Sci."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2022.114022_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.npep.2004.01.004","article-title":"Expression of the mu-opioid receptor in the anterior pituitary gland is influenced by age and sex","volume":"38","author":"Carretero","year":"2004","journal-title":"Neuropeptides"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:15:03Z","timestamp":1778242503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222014111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":45,"alternative-id":["S0753332222014111"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114022","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the expression pattern of the opioid receptor in pituitary neuroendocrine tumors (PitNET) and the role of morphine and naloxone in the regulation of pituitary cell line growth and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114022"}}